In 2024, 6 % of US adults report current GLP-1 use, and 12 % report ever userising to 22 % among individuals told by a clinician that they have overweight or obesity [2]
To put that into perspective, someone who started the trial at 300 pounds could theoretically lose about 60 pounds on tirzepatide versus roughly 41 pounds on semaglutide over about a year and four months
The limitation of lipidation: conversion of semaglutide from once-weekly to once-monthly dosing
Managing morning hyperglycemia Managing morning hyperglycemia Provide education on the causes of morning hyperglycemia and strategies to address it
[DOI] [PMC free article] [PubMed] [Google Scholar] 32.Lean M.E., Carraro R., Finer N., Hartvig H., Lindegaard M.L., Rssner S., et al
[Common Side Effects & How to Prevent Them]